Change of estrogen receptor, progesterone receptor, and Ki67 after neoadjuvant chemotherapy in patients with locally advanced breast cancer
Last updated: 28 Dec 2024
10.21608/mjmr.2022.221719
estrogen receptor, Progesterone receptor, Neoadjuvant chemotherapy
Nada
Sholkamy
H. Ali
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicin, Minia University
Wafaa
Abd El-Latif
M.
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicin, Minia University.
Mohamed
Hassan
A.
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicin, Cairo University.
yehia_mohmed@gmail.com
Amani
Guirguis
S.
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicin, Minia University.
Marian
Kamal
F.
Department of Pathology, Faculty of Medicin , Minia University
30
4
31649
2019-10-01
2022-02-24
2019-10-01
217
225
2682-4558
https://mjmr.journals.ekb.eg/article_221719.html
https://mjmr.journals.ekb.eg/service?article_code=221719
35
Original Article
2,212
Journal
Minia Journal of Medical Research
https://mjmr.journals.ekb.eg/
Change of estrogen receptor, progesterone receptor, and Ki67 after neoadjuvant chemotherapy in patients with locally advanced breast cancer
Details
Type
Article
Created At
23 Jan 2023